Growth Metrics

Maravai Lifesciences Holdings (MRVI) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$45.1 million.

  • Maravai Lifesciences Holdings' Profit After Tax rose 7387.32% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 3391.36%. This contributed to the annual value of -$259.6 million for FY2024, which is 8762.2% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Profit After Tax of -$45.1 million as of Q3 2025, which was up 7387.32% from -$69.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Profit After Tax ranged from a high of $156.7 million in Q2 2022 and a low of -$172.5 million during Q3 2024
  • Its 5-year average for Profit After Tax is $20.7 million, with a median of -$11.9 million in 2023.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 922711.51% in 2021, then crashed by 158249.26% in 2024.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Profit After Tax stood at $127.1 million in 2021, then plummeted by 31.22% to $87.4 million in 2022, then tumbled by 225.8% to -$110.0 million in 2023, then skyrocketed by 58.11% to -$46.1 million in 2024, then increased by 2.19% to -$45.1 million in 2025.
  • Its Profit After Tax stands at -$45.1 million for Q3 2025, versus -$69.8 million for Q2 2025 and -$52.9 million for Q1 2025.